Over the past ten years, immunotherapy has made significant advances in the treatment of certain cancers, particularly melanoma and lung cancer. But, for reasons that remain unclear, some people with different types of tumors respond better than others to this revolutionary treatment. In the complete search for a lever that can restore the ability of immunotherapy to awaken the immune system against cancer cells, epidrugs are the place of choice, confirmed by the results presented by the French team at the major International Congress of Oncology in Asco in Chicago.
If the genetic material (genes carried by DNA) can be considered as a guide to the activity of the organism, then epigenetics can be compared to a switch that can modify or inhibit the expression of certain genes. Thus, epigenetic drugs aim to correct the instructions given when they interfere with the cellular reaction…
Source: Le Figaro
I am John Sinkler, a professional writer and journalist for Buna Times. I specialize in writing about entertainment-related topics and have been doing so for several years now. My work has been featured on multiple platforms and I’m proud to say that it’s gained recognition from many people in the industry. Aside from working at Buna Times, I also write freelance articles for other publications.